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Abstract
Background: In malaria-endemic areas, residents of modern houses have less malaria than those living in
traditional houses. This study will determine if modern housing provides incremental protection against clinical
malaria over the current best practice of long-lasting insecticidal nets (LLINs) and prompt treatment in The Gambia,
determine the incremental cost-effectiveness of the interventions, and analyze the housing market in The Gambia.
Methods/design: A two-armed, household, cluster-randomized, controlled study will be conducted to assess
whether improved housing and LLINs combine to provide better protection against clinical malaria in children than
LLINs alone in The Gambia. The unit of randomization will be the household, defined as a house and its occupants.
A total of 800 households will be enrolled and will receive LLINs, and 400 will receive improved housing before
clinical follow-up. One child aged 6 months to 13 years will be enrolled from each household and followed for
clinical malaria using active case detection to estimate malaria incidence for two malaria transmission seasons.
Episodes of clinical malaria will be the primary endpoint. Study children will be surveyed at the end of each
transmission season to estimate the prevalence of Plasmodium falciparum infection, parasite density, and the
prevalence of anemia. Exposure to malaria parasites will be assessed using light traps, followed by detection of
Anopheles gambiae species and sporozoite infection. Ancillary economic and social science studies will undertake a
cost-effectiveness analysis and use qualitative and participatory methods to explore the acceptability of the housing
modifications and to design strategies for scaling-up housing interventions.
Discussion: The study is the first of its kind to measure the efficacy of housing on reducing clinical malaria, assess
the incremental cost-effectiveness of improved housing, and identify mechanisms for scaling up housing
interventions. Trial findings will help inform policy makers on improved housing for malaria control in sub-Saharan
Africa.
Trial registration: ISRCTN Registry, ISRCTN02622179. Registered on 23 September 2014.
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Background
There have been considerable gains made in malaria
control in sub-Saharan Africa, with malaria prevalence
dropping by half, and the incidence of clinical disease
falling by 40 % from 2000 to 2015 [1]. Yet the disease re-
mains a substantial public health problem, with 188 mil-
lion cases and 395,000 malaria deaths in 2015 [2]. The
reduction in malaria has been achieved largely by the
massive scaling up of vector control, with long-lasting
insecticidal nets (LLIN) and indoor residual spraying
(IRS). However, the future success of these interventions
is threatened by the growing problem of insecticide-
resistant mosquitoes [3], some of which are resistant to
all four classes of insecticide currently available for use
in public health [4]. Thus, an urgent need exists to de-
velop supplementary interventions that are not reliant
on insecticides. This objective is also advocated by Roll
Back Malaria (RBM) and the United Nations Develop-
ment Program (UNDP, which has stated the need for
“making actions outside the health sector essential ele-
ments of malaria control” [5]. The need for “good” hous-
ing to reduce malaria is echoed throughout this RBM/
UNDP document. Recently, the RBM Board [6], noting
that continued progress in the fight against malaria is
central to the attainment of the Sustainable Develop-
ment Goals, has committed to implementing the aim
through development of a work plan that reaches be-
yond the traditional health sector to include “environ-
ment, climate change, housing, sanitation, agriculture,
education, and other sectors invested in the fight
against poverty.” Thus, a growing enthusiasm exists
for using housing as an intervention against malaria,
as illustrated further by the new RBM workstream on
malaria and housing (http://archiverbm.rollbackmalar-
ia.org/mechanisms/vcwgWorkstream9.html).
Is housing protective? Improved housing was thought to
have contributed to the elimination of malaria in the USA
[7, 8] and to its decline in Europe [9]. Narrative reviews
suggested that “good housing” is protective in many trop-
ical countries [10, 11]. More recently, a systematic review
and meta-analysis of the literature on housing and malaria
provided stronger evidence that “good housing” is protect-
ive against malaria [12]. Residents of modern homes had
42 % lower odds of malaria infection compared to trad-
itional homes and a 54–65 % lower incidence of clinical
malaria. Yet the overall evidence indicates low quality, and
only one randomized controlled trial has been conducted
of house screening to date. This trial showed that the use
of simple untreated screens on the doors and windows
and closing the eaves in typical rural African houses re-
duced the prevalence of anemia in children by 50 % [13].
Nonetheless, the impact of “good” housing on clinical epi-
sodes of malaria, the benchmark measurement for asses-
sing malaria interventions, has not been quantified.
The hypothesis supporting housing as being protect-
ive against malaria in sub-Saharan Africa is based on
the observation that 79–100 % of malaria transmis-
sion occurs indoors at night [14]; so preventing the
entry of malaria mosquitoes indoors [10, 13] should
dramatically reduce malaria risk. Traditional thatched-
roofed houses nearly always have open eaves, with a
gap between the top of the wall and the roof, through
which Anopheles gambiae, the principal African mal-
aria vector, enters the house. Metal-roofed houses
more frequently have closed eaves, so installing
metal-roofs and closing the eaves should reduce the
entry of malaria vectors. Because screening the doors
and windows also reduces mosquito house entry [13],
we hypothesize that a combination of metal roofs,
closed eaves, and the installation of screening on the
doors and windows should measurably reduce clinical
malaria. In addition, to encourage air circulation and
help cool the room, while also preventing the entry
of mosquitoes into the intervention houses, we
propose to install screened windows and doors. Al-
though we consider the interventions safe, the possi-
bility exists that the reduced indoor airflow may
increase respiratory disease in children living in
screened houses. For this reason, we will also meas-
ure respiratory illness in our study cohort.
The long-term effectiveness and potential impact of
housing as a malaria intervention will depend on its
cost-effectiveness, acceptability to householders, and the
feasibility of implementation at scale. Therefore, along-
side the trial, we will undertake a cost-effectiveness ana-
lysis and use qualitative and participatory methods to
explore the acceptability of the housing modifications
and to design strategies for scaling up housing interven-
tions. The incremental costs and benefits associated with
house improvements, as well as the demand and supply
of construction material and skill, are invaluable data to
inform policymakers in their decision to adopt the inter-
ventions as policy. However, very limited evidence exists
on the cost-effectiveness of improved housing on health,
and the little information available is focused on inter-
ventions implemented in high-income countries [15].
Analysis of the housing sector in sub-Saharan Africa is
growing, but most of the studies are concentrated in a
few countries and in urban areas [16].
We view improved housing not as a stand-alone-
intervention but as one that should be incorporated with
established and effective vector-control interventions
such as LLINs. Thus, our goal is to determine whether
there is any additional benefit in improving rural homes
over the current best practice of using LLINs alone for
protecting children against clinical malaria, to determine
the incremental cost-effectiveness of the interventions,
and analyze the housing market in The Gambia.
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Study objectives
Clinical
Primary objective The primary clinical objective its to
assess whether improved housing (metal roof, closed
eaves, improved ventilation, and screened doors and
windows) and LLINs provide added protection against
clinical malaria in children with the LLINs alone over
two malaria transmission seasons of follow-up.
Secondary objectives
The secondary clinical objectives include the following:
 To determine whether improved housing reduces
the rate of parasite infection, parasite density, and
anemia in children
 To assess whether improved housing is associated
with a rise in respiratory infections
Entomological
Primary objective The primary entomological objective
is to assess whether improved housing and LLINs reduce
vector density inside houses when compared with the
LLINs alone.
Economic and social science
Primary objective The primary economic and social sci-
ence objective is to assess the incremental costs, bene-
fits, and cost-effectiveness of these interventions.
Secondary objective
The secondary economic and social science objectives
are as follows:
 To explore the acceptability of the house
modifications to the residents
 To analyze the housing market in The Gambia for
the identification of economic barriers to scale-up
Methods/design
Study area and participant eligibility
The study is situated in the far east of The Gambia, in
the Upper River Region (URR), an area of open Sudan
savanna. The climate consists of a single rainy season
from May to October followed by a long dry season.
This defines the highly seasonal malaria transmission,
with most malaria episodes experienced during or im-
mediately following the rainy season. This region covers
an area of 1995 km2 and is bisected by the river into the
north and south banks. The population of the region
was 182,586 in 2003, the most recent census, with most
living in small discrete rural villages in houses made with
mud or cement walls and thatched or metal roofs. The
study’s field station is based at Basse Santa Su town
(UTM coordinates 13.3167 N, -14.2167 W), which is the
only sizeable urban area in the region.
Rural villages located on the north and south bank of
the Gambia River will be selected. We will discuss the
study with village leaders, including women in each po-
tential study village, and proceed if given approval. Com-
munity sensitization will be followed by a survey to
identify suitable houses.
A total of 800 traditional thatched-roofed houses con-
structed with mud walls, open eaves, and without ceil-
ings or screening, with two children aged 6 months to
13 years, will be selected. Consent will be sought from
the house owners (and residents) for them to join the
study by field assistants (Additional file 1).
Once all houses in the intervention arm have been
modified, we will seek consent from the parents/carers
for a resident child to join the study cohort from both
arms of the study (using supplementary materials). After
explaining the purpose of the study to the household
heads, only children whose parents have given written,
informed consent for their child to be included in the
study will be enrolled (Additional file 2). The purpose of
the study and requirements of the study according to
the capability and assent sought will be explained to eli-
gible children > 12 years old.
Each arm of the study will contain 400 houses, and
one resident child will be enrolled from each house. The
child will be selected randomly from those aged
6 months to 13 years, except if they expect to be away
during several month of the transmission season. No
distinctions will be made regarding gender or ethnic
group. As much as possible, we will encourage the resi-
dents of the study houses not to move house during the
study.
Design
The study design is summarized in Fig. 1 and is a two-
armed household-clustered randomized controlled study
using a generalized, randomized, complete, block design,
with the village as the block. At least two control and two
intervention houses will be used from each village, but in-
terventions will not be introduced in > 10 % of houses in
each village to reduce the chance that mosquitoes pre-
vented from entering an intervention house will enter a
control house in greater numbers than normal. Previous
studies in The Gambia suggest that this risk is low and
that mosquito diversion is unlikely to increase exposure in
unprotected homes [17, 18]. A total of 400 houses will be
included in each arm of the study, and one resident child
will be enrolled from each house. If the resident child en-
rolled in the study leaves the house for whatever reason,
they will be replaced by another child from the same
house. The clinical study will take place over 2 years, with
clinical follow-up and entomological studies being
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conducted over two consecutive transmission seasons
(June to December); at the end of this period, households
in the control group will be provided with a metal roof
and screening if they desire it. Children will be enrolled at
the start of the first transmission season and will be
followed for clinical malaria using active case detection
(ACD) to estimate malaria incidence for two malaria
transmission seasons. These children will also be surveyed
at the beginning and end of each transmission season to
estimate the prevalence of Plasmodium falciparum infec-
tion, parasite density, and the prevalence of anemia. Ex-
posure to malaria parasites will be assessed using light
traps in 60 houses in each arm of the study, followed by
detection of An. gambiae species and sporozoite infection.
Ancillary economic and social science studies will under-
take a cost-effectiveness analysis and use qualitative and
participatory methods to explore the acceptability of the
housing modifications and to design strategies for scaling-
up housing interventions. The schedule of enrolment, in-
terventions and assessment is shown in Additional file 3.
Randomization
Since there is considerable variation in malaria risk be-
tween villages [19], houses will be randomized to the
study arms by MP, stratified by village using a computer
subroutine in a blinded manner so that an equal number
of houses are selected in each arm of the study in each
village at baseline. Every effort will be made to ensure
Fig. 1 Schematic representation of the trial
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that the arms of the study are balanced by number and
village. Furthermore, if a house leaves the study in year
1, efforts will be made to replace it in year 2. Once the
intervention is in place, one child will be selected ran-
domly and recruited from each house. The PI and trial
statistician are responsible for the house and child iden-
tification, as well as the enrollment and intervention
assignment.
A total of 120 houses will be selected for monthly light
trap collections of mosquitoes from the 800 houses en-
rolled, stratified by intervention, village, and geography
so that an equal number of houses are selected in each
arm of the study in each village, and the subsample is
equally spread over the study area.
Stratified randomization by village will reduce the like-
lihood of chance imbalances between study arms. In
addition, data on potential confounding factors including
number of people in the house, burning incense [20] will
be collected and corrected for use in the analysis. The
interventions will be closely monitored for quality and
durability and to document any bias among the villages.
Interventions
Enrolled houses will all have thatched roofs and mud
walls in good condition, and the occupants, provided
with a sufficient number of LLINs (Olyset, Sumitomo
Chemical) to cover all sleeping places. At the time of do-
nation, we will follow national guidelines to encourage
their correct use, as this is the current best practice. In
the intervention arm, represented by modern housing,
we propose to modify existing rectangular-plan and
circular-plan thatched roof houses, so they will have
metal roofs, closed eaves [19], and screening on the
doors and windows (Fig. 2, n = 400).The control arm,
representing traditional houses, will be left with thatched
roofs and open eaves (n = 400) until the end of the study.
A metal-louvered screened door will be installed in the
front of the house, and a wooden-screened door, at the
back [21]. Households will be enrolled, and the
interventions put in place from February 2015 to June
2016. Homeowners will be encouraged to keep their
doors closed at night.
Clinical data collection and patient treatments
The baseline clinical survey of all study children will
take place in May/June 2016 and will determine malaria
infection, splenomegaly, and anemia. Clinical follow-up
will start in June 2016, and cover both rainy seasons
(June to December 2016 and 2017). Incidence of clinical
malaria will be determined by ACD during twice weekly
house visits from June to November each year [20]. Clin-
ical respiratory disease will be determined at the same
time. Clinical surveys of all study children will be re-
peated at the end of each rainy season (November/De-
cember) and during June 2017. Surveys to measure
damage to the interventions and the integrity of the con-
trol houses will be carried out annually. Surveys to
measure LLIN use by all study house residents will be
made in July and October each year. The final clinical
survey of the child cohort will take place in December
2017.
No treatment will be administered by the study
personnel. However, any patient diagnosed with malaria
or suspected to have pneumonia or other illnesses will
be referred to the local health system for treatment ac-
cording to the Gambian National Guidelines.
Clinical evaluations
The main morbidity outcome will be the incidence of
clinical disease assessed by ACD; data from this will pro-
vide the primary endpoint of the study. The axillary
temperature will be taken twice weekly and if ≥ 37.5 °C,
a rapid diagnostic test (Paracheck Pf, Orchid Biomedical
Systems, Goa, India) for malaria will be made, and the
breathing rate will be checked. The presence of a cough
and either a raised age-specific respiratory rate or chest
indrawing will also be assessed in children deemed to be
unwell by the parent or guardian. Serious adverse events
Fig. 2 Prototype rectangular-plan (a) and circular-plan thatched-roof houses (b)
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(SAE) will be recorded during both transmission seasons.
Sick children will receive referral notes to the nearest
health post/facility, and treatment will be documented at
the next biweekly visit.
During the cross-sectional surveys, clinical surveys will
be done of all study children, who will be examined for
general health and the presence of an enlarged spleen. A
finger prick sample will be taken to measure the blood
hemoglobin immediately using a spectrophotometer
(HemoCue, Ängelholm, Sweden) and to prepare thick
smears for later detection and quantification of Plasmo-
dium parasites. Blood films will be stained in the field by
project staff, transported to the laboratory, and read in-
dependently by two microscopists blinded to the identity
of the child. Any discrepancy will be resolved by a third
senior microscopist. Children with sickness or disease
will be referred for treatment.
Entomological evaluations
Indoor mosquito collections made using Centers for
Disease Control (CDC) light traps will be used to esti-
mate the potential exposure to malaria vectors and will
be carried out once a month for 6 months from June to
December in 2016 and 2017 in the bedrooms of the
study children. Mosquitoes will be identified by micros-
copy, and the numbers of An. gambiae s.l. and other
species, recorded. The presence of sporozoites in An.
gambiae s.l. will be identified using an enzyme-linked
immunosorbent assay [22], and An. gambiae s.l. females,
typed to species by PCR [23].
Economic and social science evaluations
Data on incremental costs of house improvements and
their sources will be collected alongside the interven-
tions. Incremental benefits due to malaria cases averted
will be estimated based on malaria treatment cost data
collected from selected health facilities. The acceptability
of the intervention will be captured during the trial
using (1) observations and informal conversations during
the house modification process, (2) photo-voice (a par-
ticipatory action research technique enabling people to
record and reflect on their concerns, promote critical
dialogue, and reach policy makers) [24], and (3) focus
group discussions. These activities and their outputs will
contribute to the process of stakeholder engagement and
will be used to develop an end-of-trial acceptability
questionnaire survey. To design potential strategies for
scale-up, we will identify and engage with key local, na-
tional, and international level stakeholders, involving
them in discussions and decisions on the appropriate
innovation design and consideration of the implications
of the results and creating a driving team to identify
mechanisms for expansion and institutionalization while
acting as advocates for the innovation.
Safety considerations
No potential pharmacological intervention or treatment
by project staff is proposed in this study. However, the
possibility remains that our modified housing may in-
crease the risk of acute respiratory infections. We will
therefore assess the study children for respiratory disease
at each study visit, i.e., twice weekly during the transmis-
sion season. Since respiratory infections are common in
children in this area [25], we selected this age group as
the most sensitive indicator group. Adverse events,
whether attributed or not to improved housing, will be
collected. If a participant develops a SAE during the
course of the study, this will be reported by the field staff
to the study clinician within 2 days of the start of the
SAE. A SAE is defined as any adverse event that results
in death, is life threatening, requires hospitalization or
prolongation of existing hospitalization, or results in dis-
ability/incapacity. The study clinician will record and
manage the SAE in accordance with the MRC Unit
standard procedures (SOP-CTS-009 for “Recording,
Management and Reporting of Adverse Events”). The
study clinician will report the SAEs to the Chief Investi-
gator, who will report these regularly to the Data Safety
and Monitoring Committee and Study Steering Commit-
tee (SSC; see supplementary material for roles and re-
sponsibilities). All SAEs will be followed up until
resolution.
Handling of drop-outs/withdrawals
Participants are free to withdraw from the study at any
time without giving a reason. In the unlikely event that
homeowners require their house to be returned to the
pre-intervention state, we will remove the items we have
added and replace the metal roof with a thatched one.
Withdrawals may also occur if a study subject has any
clinically significant AE, laboratory abnormality, inter-
current illness, or other medical condition or situation
that occurs such that continued participation in the
study would not be in the best interest of the participant.
No replacements will be made during the surveillance
period in either year, but in May 2016, children who
have withdrawn or are no longer in the study for any
reason will be replaced by a child of a similar age from
the same house. If a household withdraws consent, no
further follow up will be made in that household. If the
house was participating in the entomology collections, it
will be replaced by a neighboring house of the same
type, if possible.
Study endpoints
Clinical
The primary clinical endpoint will be the incidence of
clinical malaria, which is determined by active case de-
tection (ACD) and defined as a body (axillary)
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temperature of ≥ 37.5 °C, together with the presence of
P. falciparum parasites detected by microscopy.
The secondary clinical endpoints will be (1) P. falcip-
arum parasite rates, (2) prevalence of splenomegaly, (3)
prevalence of anemia, and (4) an incidence of respiratory
infection, measured as a cough and either a raised age-
specific respiratory rate or chest indrawing.
Entomological
The primary entomological endpoint will be the mean
number of female An. gambiae s.l./light trap/night.
The secondary entomological endpoint will be the esti-
mated entomological inoculation rate (EIR) in each
study arm (i.e., the mean number of sporozoite infective
bites/child/season).
Economic and social sciences
The primary economic and social sciences endpoints will
be the mean and median costs of house improvement
interventions/house improved and the mean and median
costs of treating one case of childhood malaria.
The secondary economic and social sciences endpoints
will be the percentage of home owners who agreed to
house modifications in the intervention arm, key obser-
vations and discussions on house modifications with vil-
lagers and builders in the trial, trends in the types and
quantities of housing materials imported/exported, the
construction skills developed during at least the previous
5 years in the country, and a road map for scaling up of
the housing modifications.
Sample size rationale
Clinical
The combination of closed eaves and screening on the
door reduces house entry of malaria mosquitoes by 65 %
[26], and we anticipate a similar proportional reduction
in malaria incidence in the proposed study but consider
that a reduction of at least 35 % would not only be of
public health importance but also good value for the
money. We simulated incidence data allowing for
within-house correlation between the years, based on in-
cidence data collected using passive case detection from
the proposed study area in 2010 (0.0468 and 0.0442 mal-
aria episodes per child month at risk, CMAR) and 2011
(0.0321 and 0.0341 CMAR). The number of cases were
inflated twofold, as we will use active case detection
(ACD). Correlated event data were generated from a bi-
variate Poisson distribution to give random simulated
correlated counts for each house over the two years.
Each village was assumed to contain an equal number of
houses in the control and intervention arm. Fifty sets of
1,000 data points were simulated for each of the two to
ten houses in the 40 to 100 villages. The significance of
the difference in incidence rate between the control and
the intervention arms was quantified using a generalized
estimating equation (allowing for the within-house cor-
relation) with a log link for each of the data sets and
house and village parameters. The proportion of each
set of 1,000 simulations with a significant p value of less
than 5 % for the difference between the control and the
intervention arm was the estimated power. This shows
that when following one child per house for 2 years, five
houses in 80 villages are required in each study arm
(black circle, i.e., 400/arm) to detect a 35 % reduction in
malaria cases with more than 80 % power at the 5 % sig-
nificance level (Fig. 3).
Entomological
We postulate that metal-roofed houses, closed eaves,
and screening on the doors will reduce indoor collec-
tions of malaria vectors by at least 50 %. Based on a
study using light traps in the proposed study area in
2011, we expect that the mean number of female An.
gambiae s.l. per trap will be 2.11 (SD = 1.80). In order to
demonstrate a 50 % reduction in indoor-entering mos-
quitoes (i.e., unfed An. gambiae) associated with housing
interventions, with 80 % power at the 5 % level of sig-
nificance, we would require 47 houses in each arm of
the study respectively. Since the number of mosquitoes
rise and fall during the rainy season, we propose to sam-
ple from each house six times each year. To allow for
loss to follow-up during the study period, we propose to
conduct entomological monitoring in 60 houses in each
arm of the study each year.
Data handling and record keeping
The demographic data will be recorded by fieldworkers,
and the clinical data by study nurses on standardized
data forms. Each child in the cohort will be identified by
a unique identification number. All forms and datasets
Fig. 3 Sample size calculations
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will identify participants by these numbers, and names
will not be entered. The study will follow the MRC Unit
The Gambia’s specific policy to maintain anonymity of
study participants. Personal identifiers will be removed
from the transcripts of interviews, and discussions with
participants will be identified only through a study iden-
tification number. Transcribe and translated transcripts
will be entered into NVivo for management and analysis.
Participants in the photo-voice exercise will be specific-
ally requested and trained not to take photographs con-
taining images of identifiable people, and any
photographs containing such images will not be entered
into the NVivo database. Thus all data will be anon-
ymized at data entry, including those participating in the
subsidiary studies (economic and perceptions of the
housing intervention). Databases will be password pro-
tected and accessible only to authorized personnel. All
documents will be securely stored in locked filing cabi-
nets and accessible only to authorized personnel.
Source documents and access to source data
The PI will maintain appropriate medical and research
records for this study in compliance with the principles
of good clinical practice and regulatory and institutional
requirements for the protection of confidentiality of par-
ticipants. The study team members will have access to
records. The authorized representatives of the sponsor,
the ethics committee(s), or regulatory bodies may in-
spect all documents and records required to be main-
tained by the investigator, including but not limited to
medical records (office, clinic, or hospital) for the partic-
ipants in this study. The clinical study site will permit
access to such records. The results of the study will be
made publicly available. Blood slides and mosquito DNA
will be stored and made available for future studies.
Analytical plan
A per-protocol and an intention-to-treat analysis will be
conducted.
Outcome 1—malaria morbidity. Protective efficacy
against clinical malaria will be determined by comparing
incidence rates of clinical malaria between arms. After
any treatment for malaria, the child will not be consid-
ered at risk for 4 weeks, and this period will be censored.
History of travel away from the household will be cap-
tured by twice-weekly surveys during the malaria season,
and the time at risk will be censored for such periods.
An initial unadjusted analysis will be based on compari-
sons of the incidence rates between the two arms. For-
mal analysis will use a mixed effects Poisson (or negative
binomial) model to test the difference in incidence rate
between the two arms, allowing for the repeated mea-
surements within house and within village and the effect
of year. With multiple control and intervention houses
within each village, the intervention * village interaction
can also be quantified. Possible confounders such as age
of child, gender, ethnicity, and rainfall will be tested
using the mixed effects model.
A comparison of the time to the first episode of clin-
ical malaria and repeat episodes of clinical malaria will
be examined using a survival analysis approach. Initial
analyses will be based on Kaplan-Meier curves with fur-
ther adjustment for confounders performed using a Cox
regression model.
Outcome 2—malaria transmission. Differences in
malaria transmission experienced in the two groups will
be made by comparing the mean number of mosquitoes
(as a proxy for transmission) caught indoors in houses
between the intervention groups. Generalized estimating
equations will be used to estimate differences in the
numbers of indoor-resting mosquitoes, adjusting for re-
peated measures within houses and possible covariates.
Outcome 3—incremental cost-effectiveness ratio.
The incremental cost-effectiveness ratio of averting a
clinical case of malaria by home improvement interven-
tions will be calculated through probabilistic decision
tree analysis. The health impact will be also expressed in
terms of disability-adjusted life years.
Outcome 4—housing market supply. Data on the
types and quantities of construction material produced
and imported during at least the previous 5 years, as
well as of construction skills developed within the coun-
try, will be analyzed against the resources used within
the trial. Time-trend analysis will be also performed to
generate future predictions of the quantities potentially
available in the next few years, while controlling for con-
founding factors.
Blinding
Given the nature of the intervention, it is impossible
to conduct this study in a fully blinded manner, but
those parts of the data collection that can be blinded
will be. Observer bias will be reduced where feasible.
Blood films will be read by microscopists blinded to
the identity and intervention status of the subjects.
Mosquito collection bias will be reduced by using
standard light traps that do not rely on the ability of
the fieldworker to collect specimens. Trap catches
will not be examined and analyzed by those who col-
lected them but by different technicians who will not
know the trap location. Datasets will only be un-
blinded after all those critical for the listed primary
and secondary endpoints have been locked.
Trial oversight
An SSC will provide overall supervision of the trial and
ensure that the trial is conducted to the standards set
out in the Medical Research Council’s Guidelines for
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Good Clinical Practice (https://www.mrc.ac.uk/docu-
ments/pdf/good-clinical-practice-in-clinical-trials/). In
particular, the SSC will concentrate on the progress of the
trial, adherence to the protocol, patient safety, and the con-
sideration of new information, and the SSC will formally
report to the sponsor (Durham University). The Data
Monitoring Committee will determine if additional interim
analyses of trial data should be undertaken, and assess any
additional safety issues that may arise during the study.
They will ensure the safety, rights, and well-being of the
study participants and will report to the SCC at regular in-
tervals. The roles and responsibilities of the steering com-
mittees are described in Additional file 4. The completed
SPIRIT checklist is described in Additional file 5.
Ethical approval
This study is being conducted in accordance with the prin-
ciples set forth in the ICH Harmonised Tripartite Guideline
for Good Clinical Practice and the Declaration of Helsinki
in its current version, whichever affords the greater protec-
tion to the participants. It was approved by The Gambia
Government/MRC Joint Ethics Committee on 29 October
2014 (ref: SCC 1390v3) and the School of Biological and
Biomedical Sciences Ethics Committee, Durham University,
on 1 December 2014 (ref: SBBS/EC/1401/RooPfs 12 09 14).
Approval for any important protocol modifications will be
sought from both ethics committees.
Discussion
Most malaria-control interventions are based on the use
of chemicals. While drugs and vaccines are used to protect
people from the disease, insecticides are used to protect
people from potentially infective mosquito bites. The
RooPfs study is novel because we are not using chemicals
as an intervention. This is important because the major
threat to global malaria control today is from strains of
vectors that are resistant to the insecticides used for treat-
ing bed nets or spraying indoors [3]. Since vector control
with LLINs and IRS are the mainstay of malaria control
today, supplementary tools are needed to combat the
threat from insecticide-resistant mosquitoes. Improved
housing is one potential tool that could be used for mal-
aria control and is one that will be effective against
insecticide-resistant vectors. This intervention could be
used to limit malaria in areas where malaria has been
eliminated and where LLINs and IRS are no longer used.
The quality of housing is improving across many parts
of sub-Saharan Africa. Despite the global economic re-
cession, Africa’s economy is the fastest growing of any
continent (Economist 2013, Africa rising – a hopeful
continent, 2 March), and the economies of sub-Saharan
Africa are anticipated to grow at a rate of 6 % per
annum over the next decade. Such rapid development is
leading to marked changes in the housing stock with the
traditional thatched houses disappearing in many areas.
With a rapidly growing population, the need for further
housing is pressing, and this provides an opportunity for
new housing construction that will protect the occu-
pants from vector-borne diseases such as malaria.
A recent systematic review suggests that improved
housing could reduce the amount of malaria infection
and disease by half [12]. Our present study is the first to
test the assumption that modern housing will reduce the
incidence of clinical episodes of malaria in a randomized
controlled study. In the proposed study area, the inci-
dence of malaria as measured by passive case detection
is relatively low, with 0.2–0.3 children experiencing a
malaria episode during the transmission season [27].
Since clinical episodes of malaria are our primary out-
come measure, we will use ACD to maximize the num-
ber of cases. Study children will be visited twice weekly
by project staff, which should increase the number of
children diagnosed with clinical malaria. In a pilot study
in The Gambia, five cases of malaria were identified by
weekly surveillance, and eight, by daily surveillance, al-
though this difference was not statistically significant
[28]. We have selected children aged 6 months to
13 years for two reasons. First, the lower limit was se-
lected because few children experience a clinical episode
of malaria in the first 6 months of their life [29–32]. Sec-
ondly, since the level of malaria transmission of malaria
is relatively low at around 0.29–2.44 infective bites per
year for individuals sleeping without a LLIN, the burden
of clinical malaria has moved from those under 5 years
old to older age groups.
The potential risk exists to study children that screen-
ing houses from mosquitoes will reduce the air circula-
tion in the house, making it hotter, and perhaps
increasing the risk of respiratory disease. We think this
is unlikely but will record respiratory disease in the
study cohort. It should be appreciated that all study chil-
dren will be have access to LLIN at the start of the
study, and that the nets limit ventilation sharply [33]. In-
deed, it may be that the screening is so effective at redu-
cing mosquito house entry that some people living in
screened homes may stop using their nets [13]. In these
instances, air movement across subjects sleeping without
a net will be greater than those sleeping under a net.
Study subjects will benefit from this study by having a
desired commodity: a metal-roofed and screened house.
Children will also have a health check at the surveys.
However, a number of limitations exist for the use of im-
proved housing to control malaria. First, we do not
know whether the housing interventions will be accept-
able to local people. Second, we do not know how dur-
able the interventions will be. Third, this intervention is
most likely to be introduced outside the health sector, so
innovative new pathways to scale up will need to be
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developed. Finally, we are unaware of the costs of this
intervention but recognize that they are likely to be
greater than conventional vector-control strategies. All
of these issues will be addressed in ancillary studies be-
ing carried out in parallel with the randomized con-
trolled study. Furthermore, improved housing is not an
“evolution proof” intervention. If vectors adapted to en-
tering houses are prevented from doing so, it is possible
that vectors will be selected for biting outdoors, possibly
early in the evening, when they are most likely to feed.
Such changes in behavior have been seen when LLINs
or IRS have been used on a large scale [34]. This empha-
sizes the importance of using several interventions at
once, against the vector and the parasite, so that trans-
mission can be minimized and malaria eliminated in the
window before such adaptive changes occur. This proto-
col describes a randomized controlled study to measure
the impact of improved housing against malaria in Gam-
bian children.
Protocol version
17 July 2015, version 2.0.
Status
The trial is currently recruiting.
Additional files
Additional file 1: Household information sheet and consent form.
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